InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,460.80
(
0.24%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.50
(
0.45%
)
Bitcoin
65,143.68
(
1.79%
)
Post# of 504
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Ichauway

Send PM Follow Ignore
Followers 127
Posts 3024
Boards Moderated 0
Alias Born 07/24/2009

Ichauway

Member Level

Re: None

Thursday, 08/05/2021 6:55:55 PM

Thursday, August 05, 2021 6:55:55 PM

Post# of 504
$ENDP
RBC Capital " After the close, ENDP reported 2Q revenue and adjusted EBITDA of $714 million and $343 million, coming in well ahead of Street at $663 million and $291 million (see variance below). The beat reflects broad strength across all four of the company's segments, including key products XIAFLEX and Vasostrict. ENDP raised the low end of its full-year 2021 guidance for revenue, adjusted EBITDA, and adjusted EPS, and also modestly increased its product specific revenue guidance for XIAFLEX and Vasostrict."

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up